Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis

Jonathan Q Tran,1 Ahmed A Othman,2,3 Alvydas Mikulskis,4 Paul Wolstencroft,5 Jacob Elkins6 1Clinical Pharmacology, Biogen, Cambridge, MA, USA; 2Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA; 3Faculty of Pharmacy, Cairo University, Cairo, Egypt; 4Global Biomarker Disc...

Full description

Bibliographic Details
Main Authors: Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Clinical Pharmacology : Advances and Applications
Subjects:
Pharmacokinetics
daclizumab high-yield process
multiple sclerosis
Online Access:https://www.dovepress.com/pharmacokinetics-of-daclizumab-high-yield-process-with-repeated-admini-peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/pharmacokinetics-of-daclizumab-high-yield-process-with-repeated-admini-peer-reviewed-article-CPAA

Similar Items